Q1 2023 Holdings
Filed 2023-05-12 | 38 holdings | $261.8M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Travere Therapeutics Inc(TVTX) | COM | 89422G107 | $19.7M | 875,221 | 7.5% |
| Apellis Pharmaceuticals Inc(APLS) | COM | 03753U106 | $18.7M | 283,690 | 7.1% |
| Iveric BIO Inc(OPHTEUR) | COM | 46583P102 | $17.6M | 723,600 | 6.7% |
| Acadia Pharmaceuticals Inc(ACAD) | COM | 004225108 | $17.2M | 916,353 | 6.6% |
| Galapagos NV(GLPG) | SPON ADR | 36315X101 | $17.2M | 444,659 | 6.6% |
| Sarepta Therapeutics Inc(SRPT) | COM | 803607100 | $16.9M | 122,757 | 6.5% |
| Ascendis Pharma A/S(ASND) | SPONSORED ADR | 04351P101 | $16.7M | 156,072 | 6.4% |
| Sage Therapeutics Inc(SG7) | COM | 78667J108 | $16.3M | 388,865 | 6.2% |
| Amicus Therapeutics Inc(FOLD) | COM | 03152W109 | $16.2M | 1,460,175 | 6.2% |
| Prothena Corp PLC(PRTA) | SHS | G72800108 | $16.1M | 331,600 | 6.1% |
| Springworks Therapeutics Inc | COM | 85205L107 | $15.8M | 614,231 | 6.0% |
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $14.6M | 413,793 | 5.6% |
| Crinetics Pharmaceuticals in(CRNX) | COM | 22663K107 | $13.9M | 868,427 | 5.3% |
| Relay Therapeutics Inc(RLAY) | COM | 75943R102 | $13.9M | 846,270 | 5.3% |
| Arvinas Inc(ARVN) | COM | 04335A105 | $13.4M | 492,300 | 5.1% |
| Cerevel Therapeutics Hldng I(CERE1EUR) | COM | 15678U128 | $13.2M | 539,445 | 5.0% |
| Solid Biosciences Inc(SLDB) | COM NEW | 83422E204 | $2.3M | 488,857 | 0.9% |
| Ares Acquisition Corp | *W EXP 02/02/202 | G33032122 | $444.1K | 504,706 | 0.2% |
| Home Plate Acquisition Corp | *W EXP 09/30/202 | 43734R111 | $218.7K | 690,000 | 0.1% |
| Bridgetown Holdings LTD | *W EXP 09/30/202 | G1355U121 | $134.4K | 895,000 | 0.1% |
| Ross Acquisition Corp II | *W EXP 02/01/202 | G7641C114 | $115.2K | 439,666 | 0.0% |
| Conyers Park III Acquisition Corp | *W EXP 08/12/202 | 21289P110 | $114.3K | 571,666 | 0.0% |
| Churchill Capital Corp V | *W EXP 10/29/202 | 17144T115 | $114.3K | 612,000 | 0.0% |
| Marblegate Acquisition Corp | *W EXP 08/31/202 | 56608A113 | $110.2K | 735,000 | 0.0% |
| YS Biopharma Co LTD | *W EXP 03/15/202 | G9845F117 | $76.3K | 489,999 | 0.0% |
| Churchill Capital Corp VII | *W EXP 02/29/202 | 17144M110 | $67.1K | 548,000 | 0.0% |
| Afternext Healthtech Acquisition Corp | *W EXP 99/99/999 | G01109126 | $61.1K | 366,666 | 0.0% |
| Zimmer Energy Transition Acquisition Corp | *W EXP 06/16/202 | 989570114 | $60.1K | 358,270 | 0.0% |
| Jaws Hurricane Acquisition Corp | *W EXP 03/26/202 | 47201B111 | $60.1K | 387,249 | 0.0% |
| Swiftmerge Acquisition Corp | *W EXP 12/13/202 | G63836111 | $59.9K | 490,000 | 0.0% |
| Compass Digital Acquisition Corp(COMP) | *W EXP 09/29/202 | G2476C123 | $59.8K | 459,906 | 0.0% |
| Churchill Capital Corp VI | *W EXP 02/17/202 | 17143W119 | $59.4K | 540,000 | 0.0% |
| Corsair Partnering Corp | *W EXP 07/06/202 | G2540H116 | $53.6K | 334,666 | 0.0% |
| Senior Connect Acquisition COR | *W EXP 12/31/202 | 81723H116 | $51.3K | 1,014,000 | 0.0% |
| Concord Acquisition Corp II | *W EXP 99/99/999 | 20607U116 | $28.6K | 408,333 | 0.0% |
| First Light Acquisition Group Inc | *W EXP 03/14/202 | 320703119 | $26.9K | 655,200 | 0.0% |
| Bilander Acquisition Corp | *W EXP 05/19/202 | 09001T114 | $23.9K | 183,749 | 0.0% |
| Skydeck Acquisition Corp | *W EXP 05/13/202 | G82220115 | $18.1K | 361,756 | 0.0% |